Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Hana Kopecka"'
Autor:
Daisy Pireh, Stevan W. Djuric, Richard J. Sciotti, David Madar, Paul E. Wiedeman, Marina A. Pliushchev, Jonathan Pease, Hana Kopecka
Publikováno v:
Tetrahedron Letters. 42:3681-3684
A method for the intermolecular coupling of aryl bromides and oxazolidinones is described. Application to intermediates useful for the preparation of a known class of antibacterial agent and the synthesis of the known antibacterial oxazolidinone Dup-
Autor:
Karl W. Mollison, Thomas A. Fey, Donna M. Gauvin, Michael P. Sheets, Morey L. Smith, Melissa Pong, Ruth Krause, Loan Miller, Yat Sun Or, Megumi Kawai, Rolf Wagner, Paul E. Wiedeman, Richard F. Clark, Indrani W. K. Gunawardana, Teresa A. Rhoades, Cynthia L. Henry, Noah P. Tu, Nwe Y. BaMaung, Hana Kopecka, Luping Liu, Qinghua Xie, Benjamin C. Lane, James M. Trevillyan, Kennan Marsh, George W. Carter, Yung-Wu Chen, Gin C. Hsieh, Jay R. Luly
Publikováno v:
Current Pharmaceutical Design. 4:367-379
Abstract: Drug therapy for the major inflammatory skin diseases, which include atopic dermatitis, psoriasis and allergic contact dermatitis, is often inadequate due to poor efficacy, toxicity, or both. Much research has focused on the macrolactam T c
Autor:
Nan-Horng Lin, Alyssa B. O'Neill, David J. Anderson, David S. Garvey, Richard L. Elliott, Michael W. Decker, Mark W. Holladay, James P. Sullivan, Michael J. Buckley, Karen L. Gunther, Stephen P. Arneric, David E. Gunn, Keith B. Ryther, Jeffrey E. Campbell, Hana Kopecka
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:2283-2288
A series of 2-(aryloxymethyl) azetidine and pyrrolidine nAChR ligands in which the 3-pyridyl moiety of a previously described series 1 was replaced by a substituted phenyl group was explored. Aromatic substitution afforded analogues with K i values r
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 38:857-861
[ 14 C]ABT-418, (S)-3-[ 14 C]methyl-5-[N-methyl-2-pyrrolidinyl][4- 14 C]isoxazole hydrochloride, was labeled in two positions at maximum specific activity. Starting with 100 mCi of sodium [2 14 C]acetate, 14.6 mCi at 105 mCi/mmol was obtained in 8 st
Publikováno v:
Tetrahedron Letters. 36:2563-2566
ABT-418 [(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (1) is a cholinergic channel activator with potent congitive and anxiolytic activities in animal models. A three-pot synthesis of enantiomerically pure ABT-418 starting from commercially avai
Autor:
Sharon L. Kuyper, Alex M. Nadzan, Chun Wel Lin, Michael D. Tufano, Mike Stashko, Thomas R. Miller, Mark W. Holladay, Hana Kopecka, David G. Witte, Y.‐K. Shue, George M. Carrera
Publikováno v:
Bioorganic & Medicinal Chemistry. 1:161-171
New and existing methodologies were used to prepare a series of modified CCK analogs in which each amide bond was replaced by a trans-alkene unit. The data indicate that every amide linkage at C-terminal tetrapeptide (CCK-4) region is crucial for bio
Publikováno v:
ChemInform. 26
ABT-418 [(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (1) is a cholinergic channel activator with potent congitive and anxiolytic activities in animal models. A three-pot synthesis of enantiomerically pure ABT-418 starting from commercially avai
Publikováno v:
ChemInform. 26
Autor:
Richard J. Sciotti, Marina A. Pliushchev, Paul E. Wiedeman, David Madar, Stevan W. Djuric, Jonathan Pease, Hana Kopecka, Daisy Pireh
Publikováno v:
ChemInform. 32
A method for the intermolecular coupling of aryl bromides and oxazolidinones is described. Application to intermediates useful for the preparation of a known class of antibacterial agent and the synthesis of the known antibacterial oxazolidinone Dup-
Autor:
Bruce R. Bianchi, Kazumi Shiosaki, Chun Wel Lin, Alex M. Nadzan, Richard Craig, Thomas R. Miller, David G. Witte, Hana Kopecka, Michael A. Stashko
Publikováno v:
Journal of Medicinal Chemistry. 35:2007-2014
A series of Boc-CCK-4 derivatives represented by the general structure Boc-Trp-Lys(N epsilon-COR)-Asp-Phe-NH2, where R is an aromatic, heterocyclic, or aliphatic group, are potent and selective CCK-A receptor agonists. These amide-bearing compounds c